Asset Optimization & Commercialization

We can help you evaluate potential opportunities through developing a deep understanding of the current and anticipated state of scientific, competitive, and commercial environments within specific disease areas. Using bespoke-designed research with key stakeholders to ground your decision making, we can guide your acquisition and commercial development strategies. Our teams can help with:

• Scientific and Market and landscape assessment
• Horizon scanning
• Competitive analysis
• KOL research
• Analogue intelligence
• Scenario planning
• Opportunity assessment, target product profile and value development
• Early asset development and commercial strategy

We utilize a range of research techniques to guide these investment decisions, including TPP assessment, conjoint analysis, and key drivers analysis. We work with your teams to utilize the optimal research design for your project needs.

Our experience, expertise and approaches ground your scientific advances in a real world understanding of key stakeholder needs and behaviors. We help ensure that the perspective and voice of investors, strategic partners, patients, caregivers, HCPs, and payers is at the foundation of and compels your strategy. We use behavioral science techniques within both the design of our research, and the interpretation of the data uncovered, to gain an in-depth understanding of what drives behaviors, and how to disrupt and change them to lead to improved outcomes. Our teams can support you with:

• Company analogues assessment and scenario modeling
• Corporate and partnering strategy development
• Pipeline build—opportunity search and evaluation
• Target product profile and value development
• Valuation and forecasting
• Deal benchmarking and modeling
• KOL (Investor, Partner, Physician and Payer) Assessment
• Patient unmet needs assessments
• Input to clinical trial design, including patient-related outcomes
• Understanding the patient journey and treatment pathways
• Social media listening as a tool for understanding your stakeholders
• Qualitative research to assess drivers and barriers of behavior
• Qualitative and quantitative approaches to patient and HCP segmentation
• HCP omni-channel tracking with Engage
• Awareness and usage research

By ensuring insight-driven development, commercial and corporate strategies, we help you make choices that maximize opportunities, mitigate risk and drive innovation, differentiation, and value. We can help with the full range of development and commercial strategic needs, including:

• Indication prioritization and sequencing
• Valuation and forecasting
• Deal benchmarking and modeling
• Corporate and partnering strategy; search and evaluation
• Platform, asset, and brand strategy
• Portfolio and therapeutic area strategy
• Product profile optimization
• Competitor planning and response
• Positioning platform development and testing
• Communication platform optimization
• Omnichannel strategy
• Go-to-market strategy
• Commercialization strategy and launch planning
• Effectiveness and brand performance tracking